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The human paracaspase mucosa-associated lym-
phoid tissue lymphoma translocation protein 1
(MALT1) plays a central role in nuclear factor-kB
(NF-kB) signaling as both a protease and scaffolding
protein. Knocking out MALT1 leads to impaired
NF-kB signaling and failure to mount an effective
immune response. However, it is unclear to which
degree it is the scaffolding function versus the pro-
teolytic activity of MALT1 that is essential. Previous
work involving a MALT1 inhibitor with low selectivity
suggests that the enzymatic function plays an impor-
tant role in different cell lines. To help elucidate this
proteolytic role of MALT1, we have designed activ-
ity-based probes that inhibit its proteolytic activity.
The probes selectively label active enzyme and can
be used to inhibit MALT1 and trace its activity profile,
helping to create a better picture of the significance
of the proteolytic function of MALT1.
INTRODUCTION
The human paracaspase MALT1 (mucosa-associated lymphoid
tissue lymphoma translocation protein 1) plays a vital role in
nuclear factor-kB (NF-kB) signaling downstream of T and B cell
receptors (Lucas et al., 2001; Ruefli-Brasse et al., 2003; Ruland
et al., 2003). In addition, other receptors such as Dectin-1 and
G-protein-coupled receptors have also been described to signal
through MALT1 (Wegener and Krappmann, 2007). To signal,
MALT1 forms a complex with the CARD-containing proteins
CARMA1 (also known as CARD11) as well as its direct binding
partner Bcl10 (Gaide et al., 2002; Pomerantz et al., 2002; Uren
et al., 2000; Wang et al., 2002). Once the upstream signal is
received, assembly of the CARMA1-Bcl10-MALT1 (CBM) com-
plex ensues, allowing other downstream proteins such as
TRAF6 and NEMO (NF-kB essential modulator, also known as
IKK-g) to assemble upon it (Oeckinghaus et al., 2007; Sun
et al., 2004; Zhou et al., 2004). From this angle, the presumptive
protease MALT1 seems to play an important but nonproteolyticChemistry & Biology 22, 139role. However, upon its discovery almost 15 years ago (Akagi
et al., 1999; Dierlamm et al., 1999; Morgan et al., 1999), its
homology to the CD clan of proteases was noted (Uren et al.,
2000). In 2008, the first proteolytic substrates A20 and Bcl10
were discovered (Coornaert et al., 2008; Rebeaud et al., 2008),
followed by CYLD, RelB, Regnase-1, and Roquin (Hailfinger
et al., 2011; Jeltsch et al., 2014; Staal et al., 2011; Uehata et al.,
2013). In addition, the NF-kB-inducing kinase (NIK) (Rosebeck
et al., 2011) has been reported to be cleaved by an oncogenic
fusion of the cellular inhibitor of apoptosis 2 (cIAP2, also known
as AIP2) with MALT1 (cIAP2-MALT1), which occurs with varying
frequencies in MALT lymphoma of different sites (Isaacson and
Du, 2004). The effects of the cleavages have been described
elsewhere (Coornaert et al., 2008; Hailfinger et al., 2011; Jeltsch
et al., 2014; Rebeaud et al., 2008; Rosebeck et al., 2011; Staal
et al., 2011; Uehata et al., 2013), but to summarize, the cleavages
of A20 and RelB seem to have mostly fine-tuning effects on
NF-kB signaling, whereas the cleavage of Bcl10 is required for
increased cellular adhesion to fibronection after T cell activation,
andCYLD cleavage plays a role in JNK signaling. Cleavage of the
RNase Regnase-1 and the RNA binding protein Roquin disrupts
the regulation of several mRNAs, some of which are involved in
NF-kB signaling or are NF-kB target genes. The cleavage of
NIK relieves it from intramolecular inhibition through its own
TRAF3 domain and allows uncontrolled noncanonical NF-kB
signaling. The overall importance ofMALT1 for T andBcell devel-
opment has been shown using MALT1 knockout mice, which fail
to mount an effective immune response and NF-kB signaling is
prevented (Ruefli-Brasse et al., 2003; Ruland et al., 2003).
Importantly, if the proteolytic activity of MALT1 is inhibited but
the protein is still present to fulfill its scaffolding function, NF-kB
signaling is decreased but not ablated (Cabalzar et al., 2013;
Coornaert et al., 2008; Lucas et al., 2001; Rebeaud et al., 2008).
Thus, questions remain about the importance of the proteolytic
activity of MALT1. Initial results using B cell lymphoma cell lines
and the broad-spectrum protease inhibitor Z-VRPR-fluorome-
thylketone (Z-VRPR-FMK) pointed toward an important role in
the activated B cell-like subset of diffuse large B cell lymphoma
(ABC-DLBCL) (Ferch et al., 2009; Hailfinger et al., 2009). When
ABC-DLBCL cell lines were treated with Z-VRPR-FMK, cell
viability declined, providing proof that inhibiting MALT1 proteo-
lytic activity could be an important treatment option for this–147, January 22, 2015 ª2015 Elsevier Ltd All rights reserved 139
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Figure 1. Synthesis Scheme of the Probes Cy5-LVSR-AOMK and Biotin-LVSR-AOMK
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Probes to Monitor Activity of the Paracaspase MALT1aggressive form of lymphoma. However, further studies are
needed to confirm this, especially considering the low selectivity
of the inhibitor used,most likely inhibiting not onlyMALT1but also
a broad spectrum of other proteases, making clear conclusions
difficult. Amouse knock-inmodel expressing the catalyticmutant
of MALT1 (C464A) will certainly provide enlightening insights.
Here we describe inhibitory active site probes of MALT1 that
enable visualization and quantification of MALT1 activity at a
certain time point or after a stimulus. These activity-based
probes consist of a peptide sequence determining enzyme
selectivity, an electrophilic warhead, which irreversibly inhibits
the targeted protease, and a label that allows detection and
activity monitoring. Our work can be read together with a similar
independent study in this issue of Chemistry & Biology (Eitel-
huber et al., 2014).
RESULTS
Synthesis of Activity-Based Probes Directed
against MALT1
We used the cleavage site specificity determined earlier (LVSRY)
(Hachmann et al., 2012) to design MALT1 activity-based probes.
We chose an acyloxymethyl ketone (AOMK) electrophile that
preferentially inhibits cysteine proteases and has been used for
probe targeting other clan CD proteases (Berger et al., 2006;
Edgington et al., 2013; Kato et al., 2005a, 2005b; Powers et al.,
2002). We included a Cy5 fluorophore or a biotin label, which140 Chemistry & Biology 22, 139–147, January 22, 2015 ª2015 Elsevallows affinity purification as well as direct imaging of probe
modification (Figure 1).
Preferential Binding to Activated Recombinant MALT1
To test whether the inhibitors can distinguish between WT and
catalytic mutant on the one hand and activated and nonactivated
MALT1 on the other hand, we incubated purified recombinant
enzyme with Cy5-LVSR-AOMK in the presence or absence of
sodium citrate, which we and others have shown previously to
activate MALT1 in vitro (Hachmann et al., 2012; Wiesmann
et al., 2012). As shown in Figure 2, the activity-based probe
can clearly differentiate between MALT1-WT and the catalytic
mutant MALT1-C464A. No labeling is seen for the catalytic
mutant, whereas Cy5-LVSR-AOMK labels MALT1-WT in a dose-
dependent manner, confirming that the probe indeed binds the
active site. Labeling is strongly decreased in the absence of so-
dium citrate, indicating that the probe can distinguish between
active and inactive protease. That some binding is seen in non-
activating conditions is most likely due to a combination of the
high concentration of enzyme present in vitro and substrate-
induced (or in this case inhibitor-induced) generation of an active
conformation, as previously reported (Wiesmann et al., 2012;
Yu et al., 2011). As can be seen in Figure 2A, two protein species
are labeled by Cy5-LVSR-AOMK. The upper species represents
full-length MALT1, whereas the lower species was determined
via mass spectrometry analysis to most likely be a C-terminal
fragment encompassing the catalytic domain as well as theier Ltd All rights reserved
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Figure 2. Cy5-LVSR-AOMK Can Distinguish between MALT1-WT
and C464A and Preferentially Binds under Activating Conditions
(A and B) MALT1-WT or MALT1-C464A (400 nM) was incubated with Cy5-
LVSR-AOMK at different concentrations in buffer with or without citrate for
30 min at 37C, followed by TCA precipitation and SDS-PAGE. Fluorescence
was scanned (A), followed by staining with a coomassie-based protein stain
(B). Data are representative of three independent experiments.
Table 1. kobs/I Values for Inhibition of MALT1 by the Probes/
Inhibitors Used in This Study
Inhibitor kobs/I (M
1s1)
Biotin-LVSR-AOMK 9.1 (± 1.6) 3 103
Cy5-LVSR-AOMK 9.3 (± 1.6) 3 103
Z-VRPR-FMK 6.0 (± 0.7) 3 103
SEs were derived from the linear regression analyses of the kobs/I plots.
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Probes to Monitor Activity of the Paracaspase MALT1C-terminal extension including the Ig3 domain (Figure S3
available online). The minimal number of peptides observed in
mass spectrometry originating from the N-terminal region of
MALT1 is likely carryover in the gel from the full-length protein.
The intriguing idea that the C-terminal fragment could be an
autoproteolytic cleavage product is contradicted by the fact
that the catalytic mutant also shows this product. Since no frag-
ments of this size are seen in cell culture experiments and no
convincing cleavage sites are found in the sequence preceding
the catalytic domain, we conclude that the cleavage ismost likely
due to an E. coli protease during expression and represents an
in vitro artifact leading to two active species.
To confirm that probe binding indeed leads to the inactivation
of the enzyme and to obtain evidence that biotin-LVSR-AOMK
also binds and inhibits MALT1, we measured the MALT1 rate
of inhibition. Pseudo first-order calculations (Table 1) revealed
that the rate of inhibition is at least in the range of 103 M1s1
for the inhibitors Cy5-LVSR-AOMK and biotin-LVSR-AOMK,
slightly exceeding the rate of inhibition of the previously used
inhibitor Z-VRPR-FMK.
Detection of MALT1 Activity upon Ectopic Expression
in Mammalian Cells
We next determined whether the activity-based probes can be
used to detect active versus inactive MALT1 in lysates from aChemistry & Biology 22, 139mammalian cell line transfected with the enzyme. MALT1 activity
has been reported to be activated upon its co-overexpression
with Bcl10 (Coornaert et al., 2008; Rebeaud et al., 2008). We
therefore overexpressedMALT1 and Bcl10 in different combina-
tions in human HEK293A cells, followed by cell lysis in the pres-
ence of probe, SDS-PAGE, and western blot analysis. As shown
in Figure 3A, overexpression of MALT1-WT in combination with
Bcl10 leads to Cy5 fluorescence of a protein species around
100 kDa. Overexpression of MALT1 alone shows fluorescence
as well, albeit to a much lesser degree. Overexpression of
Bcl10 alone or in the presence of MALT1-C464A likewise leads
to the appearance of a faint fluorescently labeled protein.
Note that the small size difference is due to the Flag-tag of
the overexpression construct. No fluorescence can be seen
when MALT1-C464A is expressed alone, again indicating that
Cy5-LVSR-AOMK cannot bind the catalytic mutant but requires
an intact active site. Furthermore, these data confirm that the
probe has generally low cross-reactivity toward other proteins
in the cell.
To inhibit binding of the probe to cathepsins, members of
cysteine protease clan CA—some of which have substrate spec-
ificities that could overlap with MALT1—all samples contained
the protease inhibitor E-64, which has been shown to potently
inhibit cathepsins (Barrett et al., 1982). Under these experimental
conditions, the probe bound most strongly to MALT1, and only a
faint additional species around 31 kDa was seen. To determine
whether this cross-reactivity would increase in the absence of
E-64, we omitted the inhibitor from one sample. No significant
intensity increase of the 31 kDa species could be seen, suggest-
ing that the probe does not substantially cross-react with
cathepsins, further validating its high degree of selectivity.
The biotin probe also enables the detection of active MALT1
after overexpression of MALT1-WT and Bcl10 (Figure 3B).
No other probe-labeled proteins were detected, most likely
due to the lower overall intensity of the biotin probe. Overall, it
can be concluded that both probes can label and inhibit active
MALT1 obtained from total cell lysates after overexpression in
HEK293A cells.
The blot for MALT1 antigen reveals two species, one at
approximately the same size as endogenous MALT1, which
can be seen in the nontransfected samples, and one that mi-
grates at approximately 10 kDa lower. The lower species is not
detected by the Flag antibody if the Flag-tag is placed at the
N instead of C terminus (Figure S4). In the WT overexpression
samples, this protein species is labeled by the probe, suggesting
that it represents an active C-terminal fragment. The fragment
does not match the size of the species observed in the recom-
binant E. coli-produced samples (Figure 2). Again, both WT
and mutant MALT1 are cleaved, and the question remains–147, January 22, 2015 ª2015 Elsevier Ltd All rights reserved 141
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Figure 3. Cy5-LVSR-AOMK and Biotin-LVSR-AOMK Can Detect Active MALT1 after Overexpression
(A and B) Different combinations of Bcl10, MALT1-WT, or C464A, respectively, were overexpressed in HEK293A cells. Cells were lysed in the presence of
Cy5-LVSR-AOMK (A) or biotin-LVSR-AOMK (B), respectively, precleared, and subjected to SDS-PAGE, fluorescence scanning, and western blot analysis with
the indicated antibodies. E-64 was added or omitted in the lysis buffer to control for cathepsin binding of the probe. Note that endogenous and Flag-tagged
versions of the proteins migrate slightly differently during the SDS-PAGE. The asterisks mark nonspecific bands. Data are representative of three independent
experiments.
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Probes to Monitor Activity of the Paracaspase MALT1whether the cleavage is autocatalytic or caused by another
protease. It is theoretically possible that endogenous WT
MALT1 performs the cleavage in the mutant samples. However,
this seems unlikely because the cleavage occurs to the same
extent in all samples. While we did not further investigate this
phenomenon, we speculate that MALT1 is cleaved by another
protease. Whether this is only the case when MALT1 is overex-
pressed or whether it also occurs at endogenous levels cannot
be definitively concluded due to the low intensity of the endoge-
nous protein.
Cy5-LVSR-AOMK Can Detect Endogenous MALT1
Activity in OCI-Ly3 ABC-DLBCL Cells
Having established that MALT1 activity can be detected in an
overexpression system, we wanted to determine whether the
more sensitive probe Cy5-LVSR-AOMK can be used to detect
MALT1 activity in ABC-DLBCL cell lines. These have previously
been reported to exhibit constitutive MALT1 activity, whereas
cell lines derived from the germinal center B cell-like DLBCL sub-
type (GCB-DLBCL) did not (Ferch et al., 2009; Hailfinger et al.,
2009). As shown in Figure 4A, the probe was able to visualize
MALT1 activity in the ABC-DLBCL cell line OCI-Ly3, but not
the ABC-DLBCL cell line OCI-Ly10 nor theGCB-DLBCL cell lines
SUDHL-4 and BJAB (note that the faint fluorescent signal visible
around 97 kDa in lanes 2–4 does not match in size with the
MALT1 species detected by the antibody). While we were sur-
prised to see the difference between OCI-Ly3 and OCI-Ly10
cells, the result nonetheless proved that the probe was sensitive
enough to detect endogenous MALT1 activity and directly
confirmed the constitutive MALT1 activity of OCI-Ly3 cells
shown indirectly in previous publications (Ferch et al., 2009; Hail-
finger et al., 2009). We asked why we could not observe activity
of MALT1 as claimed previously for OCI-Ly10 cells (Ferch et al.,142 Chemistry & Biology 22, 139–147, January 22, 2015 ª2015 Elsev2009; Hailfinger et al., 2009). Along these lines, we observed a
decrease in signal intensity generated by active MALT1 in the
OCI-Ly3 cell line with increasing time in culture. Upon thawing
of a fresh vial, the signal was back to its initial intensity (data
not shown). This shows that culture conditions can lead to
changes that affect MALT1 activity. While we could not solve
the discrepancy between our results concerning MALT1 activity
for the OCI-Ly10 cell line and previously published data, we
speculate that culture conditions and subclones could well
cause differences in MALT1 activity. Possibly, lymphoma-
derived cells initially under the influence of MALT1 as a driver
mutation become insensitive and acquire additional survival
characteristics during prolonged passages. This speculation is
consistent with our findings, but further clarification is beyond
the scope of the current work. However, since our results
show that the probe can detect active MALT1 if present at suffi-
cient concentrations, such as in OCI-Ly3 cells or under overex-
pression conditions, it has the potential to help determine
whether MALT1 is active in the cells and conditions investigated
in a given study.
Several additional fluorescent bands (visible at lower mole-
cular weights around 45, 31, and 14 kDa) were detected in all
DLBCL lines, but their intensities were lower than that of the fluo-
rescent MALT1 species at approximately 90 kDa. To investigate
whether these species represent active cleavage products of
MALT1 or nonspecific binding of the probe, we preincubated
OCI-Ly3 cells with increasing concentrations of the reversible
MALT1 inhibitor mepazine (Nagel et al., 2012; Schlauderer
et al., 2013). This caused a dramatic decrease in the intensity
of the fluorescent species at 90 kDa, while the intensity of the
lower molecular weight species remained unchanged, suggest-
ing that they represent nonspecific probe binding rather than
MALT1 cleavage products. There is a formal possibility that theier Ltd All rights reserved
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Figure 4. Cy5-LVSR-AOMK Can Detect Active Endogenous MALT1 in OCI-Ly3 Cells
(A) The ABC-DLBCL cell lines OCI-Ly3 and OCI-Ly10 and the GCB-DLBCL cell lines SUDHL-4 and BJAB were lysed in the presence of Cy5-LVSR-AOMK and
E-64, precleared, and subjected to SDS-PAGE, fluorescence scanning, and western blot analysis with the indicated antibodies. Note that the MALT1 band
detected via Cy5 fluorescence in the OCI-Ly3 sample correlates with the band detected by the MALT1 antibody at90 kDa (lane 1). The faint fluorescent bands
visible in lanes 2–4 do not correspond to the species detected by the antibody but migrate at a slightly higher molecular weight.
(B) OCI-Ly3 cells were treated with the indicated concentrations of mepazine for 4 hr, followed by lysis as in (A) except that the lysis buffer was supplementedwith
the appropriate concentrations of mepazine. Data are representative of three independent experiments. IB, immunoblot.
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Probes to Monitor Activity of the Paracaspase MALT1bands represent MALT1 cleavage fragments insensitive to me-
pazine. However, considering that the cross-reacting species
are seen equally in all investigated DLBCL cell lines regardless
of MALT1 activation status, it seems unlikely that the species
are MALT1 cleavage products. The identity of the cross-reacting
species was not investigated further at this point. Overall, Cy5-
LVSR-AOMK was successfully used to detect active endoge-
nous MALT1, and the constitutive activity of MALT1 in OCI-Ly3
ABC-DLBCL cells was confirmed in a direct manner.
Endogenous Active MALT1 Is Mostly NP40 Soluble,
while Overexpression Leads to the Formation
of NP40-Insoluble Aggregates
After establishing that the activity-based probes can label active
MALT1 in cell lysates, we deployed the Cy5 probe to address
questions of MALT1 biology. The localization and assembly
of components of the CBM complex have been subjects of
considerable research with varying results depending on activa-
tion status and overexpression versus endogenous proteins
(Che et al., 2004; Gaide et al., 2002; Guiet and Vito, 2000;
Izumiyama et al., 2003; Qiao et al., 2013; Rossman et al., 2006;
Schaefer et al., 2004; Yan et al., 1999). Until now it has not
been possible to differentiate between active material and total
protein. To determine the subcellular location of MALT1 activa-
tion, we employed imaging flow cytometry and confocal micro-
scopy. Our results were equivocal (data not shown), which we
attribute to the hydrophobic nature of the Cy5 probe, such that
even after extensive washing it remained partially bound to cells.
This rendered it difficult to distinguish between cell penetrationChemistry & Biology 22, 139and nonspecific binding to the outside of cells. We conclude
that the Cy5 probe shows at best low cell penetration potential
and that further optimization is needed if the probe is to be
utilized for the detection and inhibition of MALT1 in intact cells.
Notwithstanding this limitation, we were able to obtain data on
cell compartmentalization comparing endogenous versus over-
expressed Bcl10 andMALT1 by employing differential detergent
extraction. In the endogenous scenario, OCI-Ly3 cells constitu-
tively activate MALT1 due to an activating mutation in CARMA1
(Lamason et al., 2010; Lenz et al., 2008). In the overexpression
scenario, high protein concentrations of Bcl10 and MALT1 in
HEK293A cells activate the protease, most likely by causing
constitutive oligomerization. In OCI-Ly3 cells, the majority of
endogenous MALT1, both active and total protein, as well as
Bcl10, was detected in the NP40-soluble fraction (Figure 5A).
This allowed us to conclude that the majority of active and total
MALT1 is either present in soluble form in OCI-Ly3 cells or in
a form that is solubilized under the lysis conditions used. In
stark contrast to the OCI-Ly3 cell line, the overwhelming
amount of active MALT1 was detected in the NP40-insoluble
fraction upon ectopic coexpression of MALT1 and Bcl10 in
HEK293A cells (Figure 5B). Bcl10 was divided relatively evenly
between the NP40-soluble and -insoluble fractions, whereas
MALT1 protein was only present at substantial amounts in
the NP40-insoluble fraction when coexpressed with Bcl10.
Importantly, when overexpressed alone, MALT1 remained
soluble. Significant amounts of cleaved Bcl10 are seen only in
the NP40-insoluble fraction of cells overexpressing both Bcl10
and MALT1-WT, confirming that probe binding correlates with–147, January 22, 2015 ª2015 Elsevier Ltd All rights reserved 143
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Figure 5. Endogenous MALT1 Is NP40 Soluble, whereas Over-
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(A and B) OCI-Ly3 cells (A) or HEK293A cells transfected as indicated (B) were
lysed in the presence of Cy5-LVSR-AOMK, followed by centrifugation and
separation of the lysates into NP40-soluble and -insoluble fractions, SDS-
PAGE, fluorescence scanning, and western blot analysis with the indicated
antibodies. Data are representative of three independent experiments.
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Probes to Monitor Activity of the Paracaspase MALT1MALT1 proteolytic activity. The fact that the majority of cleaved
Bcl10 is detected in theNP40-insoluble fraction together with the
vast majority of active MALT1 suggests that Bcl10 associated
with active MALT1 is cleaved preferentially.
We conclude that upon overexpression Bcl10 forms NP40-
insoluble aggregates that contain a large fraction of total
Bcl10. MALT1, on the other hand, stays soluble when over-
expressed alone, but is recruited to the aggregates upon co-
overexpression with Bcl10. Whether active MALT1 seen in the
NP40-soluble fraction originates from MALT1 that is active
outside of the aggregates or whether the aggregates are
partially solubilized during lysis releasing some of the active
MALT1 could not be determined from the experimental setup.
Because of the formation of NP40-insoluble aggregates, we
conclude that total cell lysates should be used for analysis
when studying the CBM complex to avoid missing crucial
information.144 Chemistry & Biology 22, 139–147, January 22, 2015 ª2015 ElsevMutation of MALT1 at K644 Decreases but Does Not
Eliminate MALT1 Activity
As another example of probe application, we investigated the
importance of ubiquitination for MALT1 activity. It has been re-
ported that monoubiquitination of MALT1 at K644 is essential
for its proteolytic activity (Pelzer et al., 2013). We created the
ubiquitin mutant K644R and checked its effect on MALT1 activ-
ity using probe binding as a readout. While overexpression
of the catalytic mutant C464A lowered Cy5 probe binding to
endogenous levels, the K644R mutant still bound the probe.
It was substantially decreased compared with MALT1-WT,
but ubiquitination at K644 was clearly not a requirement for
MALT1 activity per se, which was supported by the decreased
but clearly detectable level of Bcl10 cleavage seen in the
K644R sample.
DISCUSSION
We have described probes that can distinguish between active
and inactive MALT1 both in the recombinant in vitro setting
and in cell lysates.
After purification of MALT1 from E. coli, two distinct species
are visible upon SDS-PAGE analysis that correspond to full-
length MALT1 and a C-terminal fragment, respectively (Figures
2 and S3). Both represent active species of MALT1 and show
probe binding. It is interesting to note that the fluorescence
intensity of the two protein species is approximately equal in
the sodium citrate containing samples even though the upper
species is more abundant, as shown by the coomassie stain.
In the absence of citrate, labeling of the C-terminal fragment
is strongly decreased compared with full-length enzyme. We
speculate that this could be due to the absence of the N-terminal
domains in this fragment, which have been reported to self
oligomerize (Qiu and Dhe-Paganon, 2011). In the presence of
sodium citrate, these domains might not play as important a
role as in its absence.
Comparing the localization of MALT1 and Bcl10 protein in
endogenous versus overexpression conditions revealed a clear
discrepancy (Figure 5). While overexpressed active MALT1
localized predominantly in the NP40-insoluble fraction, active
endogenous MALT1 was detected mostly in the NP40-soluble
fraction. These results provide an example of how overex-
pression may create artificial conditions that do not accurately
represent endogenous cellular processes. It remains to be deter-
mined whether accumulation in the NP40-insoluble fraction is
simply due to higher protein levels upon overexpression, driving
the formation of larger complexes that reach a critical size and
thus become NP40 insoluble, or whether an entirely different
mechanism of activation occurs under the different conditions.
In case of the latter, it would be interesting to reexamine the
recent results pertaining to the filamentous aggregate structure
of the CBM complex (Qiao et al., 2013).
Considering the NP40-insoluble nature of overexpressed
active MALT1, we reevaluated the results shown in Figure 3 for
which NP40-soluble material only had been analyzed. Even
though we had to conclude that the amount of active MALT1
was most likely underestimated due to the experimental condi-
tions, the main conclusion—that both Cy5-LVSR-AOMK and
biotin-LVSR-AOMK can detect active MALT1 and distinguishier Ltd All rights reserved
Figure 6. Mutation of MALT1 at K644 Decreases Its Activity
HEK293A cells were transfected as indicated and lysed in the presence
of Cy5-LVSR-AOMK, followed by SDS-PAGE of total cell lysates (no separa-
tion into NP40-soluble and -insoluble fractions), fluorescence scanning, and
western blot analysis with the indicated antibodies. Note that the antibodies
detect both endogenous and Flag-tagged versions of the proteins, which
migrate at a slightly different molecular weight. In addition, the MALT1 anti-
body detects MALT1 cleavage products of unknown significance, and the
Bcl10 antibody detects multiple higher molecular weight species, which most
likely represent posttranslationally modified variants. Data are representative
of three independent experiments.
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ditions—remains valid.
When we elucidated the significance of MALT1 mutation at
K644, which has been reported to alter a ubiquitination site
important for its proteolytic activity (Pelzer et al., 2013), we deter-
mined that while the mutation clearly decreases MALT1 activity,
ubiquitination at this site does not seem to be an absolute
requirement (Figure 6). It is important to note that we could not
detect a distinct higher molecular weight species representing
ubiquitinated MALT1, which could be due to a lack of resolution
during SDS-PAGE analysis. Another explanation could be the
activity of deubiquitinating enzymes (DUBs) during lysis. The
detection of ubiquitinated protein species is challenging due to
the highly reversible nature of the modification. For efficient
detection the cysteine alkylator N-ethylmaleimide (NEM) is
commonly employed to inhibit DUBs, but in our case, this was
not feasible because NEM also inhibits the cysteine protease
MALT1 and probe binding. Therefore, we might be slightly
underestimating the significance of ubiquitination for proteolytic
activity. However, the important point is that in the absence of
ubiquitination—whether achieved through the K644R mutation
or DUBs—the probe still detects active MALT1. This, in combi-
nation with the fact that Bcl10 cleavage is decreased but not
eliminated upon expression of the K644R mutant, points to a
supporting role for ubiquitination at K644, although possibly
not as essential as suggested in a previous report (Pelzer et al.,
2013).
Another interesting observation when comparing the K644R
mutant and WT enzyme is that MALT1 seems to be partially
cleaved, resulting in a slightly smaller fluorescent species
than full-length enzyme. Compared with the K644R mutant, theChemistry & Biology 22, 139cleavage is preferentially seen in the WT enzyme, and no
cleavage is detected at all in the catalytic mutants, whether
they retain their ubiquitin binding site or not. This raises the
exciting possibility that the cleavage could potentially be auto-
catalytic. The difference in size is very small and more readily
detected via fluorescence than by immunodetection. Probe
fluorescence is therefore a powerful tool that can be used to
detect small but potentially important effects involving MALT1
activity.
SIGNIFICANCE
We have developed two activity-based probes that specif-
ically bind and inhibit active MALT1. The probes can differ-
entiate effectively between active and inactive MALT1 both
when using recombinant enzyme, cellular overexpression,
and endogenous MALT1 in an ABC-DLBCL cell line.
We have therefore provided tools that allow the monitoring
of MALT1 activity. As examples of probe application,
we compared the subcellular localization of active MALT1
under endogenous and overexpression conditions as well
as the influence of ubiquitin modification of MALT1 at K644
on its activity. We propose that these tools will prove to be
useful in further elucidating MALT1 and the importance of
its scaffolding versus proteolytic function.
EXPERIMENTAL PROCEDURES
Probe Synthesis
See the Supplemental Information for a detailed description of the probe
synthesis.
Protein Expression
Recombinant full-length MALT1 was expressed and purified as previously
described (Hachmann et al., 2012).
Plasmids
Full-length MALT1 optimized for human expression (WT and catalytic mutant
C464A, respectively), and Bcl10 were cloned into pcDNA3.1 containing a
C-terminal Flag-tag. The K644R mutant was obtained using site-directed
mutagenesis and cloned into the same vector as MALT1-WT and C464A.
Incubation of Recombinant MALT1 with Cy5-LVSR-AOMK
Recombinant MALT1 and Cy5-LVSR-AOMK were incubated 30 min at 37C in
MALT1 assay buffer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid, 100 mM NaCl, 10 mM dithiothreitol (DTT), 1 mM EDTA [pH 7.5]) with or
without 0.9 M sodium citrate, followed by trichloroacetic acid (TCA) precipita-
tion and SDS-PAGE using 4%–12% Bolt Bis-Tris gels (Life Technologies).
Fluorescence was scanned at 700 nm using an Odyssey infrared scanner
(LI-COR Biosciences), and total protein was visualized using coomassie-
based InstantBlue stain (expedeon).
Inhibition Kinetics
Recombinant full-lengthMALT1was incubated with increasing concentrations
of inhibitor in MALT1 assay buffer with 0.9 M sodium citrate in the presence of
100 mM of the synthetic tetrapeptide substrate Ac-LRSR-AFC (SM Biochemi-
cals). Kinetics of inhibition were evaluated by monitoring the release of the
fluorophore over time using a Gemini Molecular Devices microplate spectro-
fluorometer. Progress curve data were analyzed by least-squares analysis
using GraphPad Prism to determine the pseudo first-order rate constant
kobs. Derived second-order rate constants (kobs/I) were calculated taking into
account the factor (1 + S/Km), where S is the substrate concentration and
Km determined as 37.4 mM (Hachmann et al., 2012).–147, January 22, 2015 ª2015 Elsevier Ltd All rights reserved 145
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HEK293A cells were cultured in Dulbecco’smodified essentialmedium supple-
mentedwith 10% fetal bovine serum (FBS), L-glutamine, and antibiotics. Trans-
fections were performed when the cells had reached a density of 50% using
the NanoJuice transfection reagent (Novagen) according to the manufacturer’s
instructions.Cellswerecultured for 24hr after transfection. TheDLBCLcell lines
OCI-Ly3, OCI-Ly10, SUDHL-4, and BJABwere a generous gift from the labora-
tory of John C. Reed, Sanford-Burnham Medical Research Institute. OCI-Ly3
and OCI-Ly10 were cultured in Iscove’s modified Dulbecco’s medium supple-
mentedwith 20%humanAB serum (Corning), L-glutamine, b-mercaptoethanol,
and antibiotics. SUDHL-4 and BJAB were cultured in RPMI 1640 medium sup-
plemented with 10% FBS, L-glutamine, b-mercaptoethanol, and antibiotics.
Cell Lysis and Inhibitor Treatment
At 24 hr after transfection, cells were trypsinized and washed with PBS before
lysis with a buffer containing 10 mM Tris (pH 7.4), 75 mM NaCl, 5 mM EDTA,
1% Nonidet P-40 (NP40), supplemented with 10 mM DTT and protease inhib-
itors (E-64, MG-132, 3,4-DCI (3,4-dichloroisocoumarin), and leupeptin, all at
10 mM) unless noted otherwise. For the detection of endogenous MALT1 in
DLBCL cells, 2 3 106 OCI-Ly3 cells or 6 3 106 OCI-Ly10, SUDHL-4, or
BJAB cells, respectively, were washed with PBS and lysed as described
above. Where applicable, Cy5-LVSR-AOMK or biotin-LVSR-AOMK, respec-
tively, were added to the lysis buffer at 1 mM. Cells were lysed 15–30 min
at 37C, followed by centrifugation and separation into NP40-soluble and
-insoluble fractions. Alternatively, in Figure 6, total cell lysates were obtained
by adding SDS sample buffer to the uncleared lysates. Total cell lysates and
NP40-insoluble fractions were sonicated to ensure complete solubilization.
The lysates were resolved via SDS-PAGE, followed by fluorescence scanning
at 700 nm using an Odyssey infrared scanner (LI-COR Biosciences), transfer
onto nitrocellulose membrane, and antibody detection. Mepazine hydrochlo-
ride was a generous gift from the laboratory of Daniel Krappmann, Helmholtz
Zentrum Mu¨nchen-German Research Center for Environmental Health, Insti-
tute of Molecular Toxicology and Pharmacology.
Antibodies
Anti-MALT1 antibody was from Santa Cruz (B-12). Anti-Bcl10 was from Cell
Signaling (4237). Anti-Flag was from Sigma-Aldrich (clone M2). Anti-b-tubulin
was from Abcam (ab6046). IRDye 800CW Streptavidin (LI-COR Biosciences)
was used for biotin detection.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.chembiol.2014.11.011.
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